Applied Evidence

Sport-related concussion: How best to help young athletes

Author and Disclosure Information

 

From The Journal of Family Practice | 2016;65(8):538-544,546.

References

Overseeing the return to play

Return-to-activity progression follows a stepwise protocol, with 6 steps that the injured athlete must complete before resuming full activity (FIGURE 1A).8-10 This stepwise progression begins only when athletes are symptom free, even during provocative maneuvers; have had a normal neurologic exam, are back to school full time with no restriction; are off any medications prescribed for concussion symptoms (TABLE 4),8-10 and when neurocognitive testing, if performed, is back to baseline. If an athlete develops symptoms at any stage of the progression, rest is required until he or she remains asymptomatic for at least 24 hours. The progression is then restarted at the last stage at which the patient was symptom free.

Some individualization, of course, is recommended here, too. Younger athletes and those with a prior history of concussion may require 10 days or more to complete all the steps, allowing an extra day at various steps. Neurologic maturation affects recovery time, and for younger individuals, a more conservative return-to-play protocol based on initial concussion symptom duration has been proposed (FIGURE 1B).16

Return to activity is often supervised by a certified athletic trainer at the athlete’s school. In the event that no athletic trainer is available, patients may be referred to physical therapists with experience in monitoring injured athletes.26 Anyone involved in the patient’s care, including the athlete himself, may use a symptom checklist to monitor recovery.

Allowing asymptomatic athletes to engage in non-contact sports activity less than 7 to 10 days after concussion can help them avoid injury when they are cleared for full play.

Although there is no evidence that the ongoing use of a symptom checklist affects the course of recovery, its use is often helpful in identifying specific symptoms that can be managed by means other than physical and cognitive rest—a sleep hygiene program for an individual with lingering difficulty sleeping, for example, or the continued application of ice, heat, and massage for persistent neck pain.

Checklist monitoring may be especially helpful for athletes whose symptoms extend beyond 10 days or who have multiple symptoms. Final clearance once all the steps have been completed requires follow-up with a health care provider.

Is a symptom-free waiting period necessary?

There is no evidence suggesting a need for a symptom-free waiting period before starting the return-to-play protocol.10,27 Because a repeat concussion is most likely within 7 to 10 days of the initial injury,8,9 however, most athletes should not return to contact play during that time frame, regardless of symptom resolution.

It is helpful to have asymptomatic athletes participate in non-contact activity before the 7 to 10 days are up, however. Doing so can help prevent deconditioning and injury upon return to contact sport, as there is evidence of increased risk of lower-extremity injury in the 90 days after concussion.28

Pages

Recommended Reading

Start time for estrogen conveys no cognitive impact
MDedge Family Medicine
Withdrawing risperidone spikes risk for psychotic relapse in hallucinating Alzheimer’s patients
MDedge Family Medicine
VIDEO: Loss of function in Rab10 gene cuts Alzheimer’s risk by up to 40%
MDedge Family Medicine
VIDEO: Medicare pays billions for potentially avoidable hospital admissions in dementia patients
MDedge Family Medicine
Experts offer blueprint for transitioning youth with neurologic conditions
MDedge Family Medicine
Medicare annual wellness visit remains underused
MDedge Family Medicine
VIDEO: Proposed Alzheimer’s funding boost could mean wider research scope
MDedge Family Medicine
VIDEO: Alzheimer’s anti-tau drug fails, but shows hint of effect when taken alone
MDedge Family Medicine
AAN recommends against routine closure of patent foramen ovale for secondary stroke prevention
MDedge Family Medicine
Alzheimer’s anti-tau drug fails phase III, but posts some benefit in monotherapy subanalysis
MDedge Family Medicine